This site is intended for Healthcare professionals only.

Panacea Biotec, Bionpharma join hands for generics drugs worth Rs 5,130 crore

Panacea Biotec, Bionpharma join hands for generics drugs worth Rs 5,130 crore

New Delhi: Drug firm Panacea Biotec said it has entered into a joint collaboration with the US generic drug maker Bionpharma for development, licence, manufacturing, supply and sales of seven complex generic products.

Panacea Biotec said the joint collaboration is for commercialisation of seven abbreviated new drug applications under development, representing a total estimated market potential of more than USD 800 million (Rs 5,130 crore).

Under the collaboration, Panacea will be responsible for development, filing, registration, manufacturing and supply of these ANDAs, it said in a BSE filing.

Bionpharma will be responsible for importation, warehousing, sales and distribution of these ANDAs in the US and its territories.

Under a previous arrangement, Bionpharma is also the exclusive distributor for companys 2 ANDAs in the US market.

These ANDAs have already been commercialised under a separate exclusive licence and supply agreement.

READ  US judge orders Pharma Bro to give up 7.36 million dollars


Source: PTI
0 comment(s) on Panacea Biotec, Bionpharma join hands for generics drugs worth Rs 5,130 crore

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted